An Aerosol is a tiny solid particle or liquid droplet suspension in air or some other gas. Aerosols can be both natural and man-made. Natural aerosols include fog or mists, dust, forestry exudates, and geyser steam. Particulate air pollution, mist from hydroelectric dam discharge, irrigated mist, perfumes from atomizers, smoking, steam from a kettle, sprayed insecticides, and medical interventions for respiratory disorders are all examples of anthropogenic aerosols. An anthropogenic aerosol is inhaled whenever a person breathes the contents of a vape pen or e-cigarette. Aerosol particles are generally smaller than 1 m in diameter. Aerosol concentration may be measured in a number of ways. The mass concentration (M), defined as the mass of particulate matter per unit volume and expressed in units such as g/m3, is frequently used in environmental research and environmental health. The number concentration (N) is another term for the number of particles per unit volume, which is measured in measures such as number per m3 or number per cm3. The aerosol particle radius or diameter (dp) is an important parameter used to characterise aerosols. Aerosol dispersion varies. A monodisperse aerosol, which may be created in the lab, comprises uniformly sized particles. However, most aerosols, being polydisperse colloidal systems, have a wide range of particle sizes.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Storage stability and solution binding affinity of an fc-fusion mimetic
Hanieh Khalili, University of East London, United Kingdom
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia